Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Jazz Pharmaceuticals
Bayer
Rutgers, The State University of New Jersey
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
University of California, Davis
Psyence Australia Pty Ltd
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Daiichi Sankyo
Brigham and Women's Hospital
Mayo Clinic
Seagen Inc.
Tempus AI
GlaxoSmithKline
University of California, Irvine
Elevation Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Exelixis
National Institutes of Health Clinical Center (CC)
Sun Yat-sen University
Universitair Ziekenhuis Brussel
Convalife (Shanghai) Co., Ltd.
pharmaand GmbH
Hoffmann-La Roche
AstraZeneca
OncoNano Medicine, Inc.
National Institutes of Health Clinical Center (CC)
Main Line Health
NRG Oncology
ExcellaBio LLC
Mary Crowley Medical Research Center
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Novartis
University of Oxford
City of Hope Medical Center
Washington University School of Medicine
Takeda
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
The University of Texas Health Science Center at San Antonio